Browsing by Subject
Now showing items 1-7 of 7
-
Avances en tumores del estroma gastrointestinal: ¿hacia dónde vamos?
(Permanyer, 2022) -
Cabozantinib combination therapy for the treatment of solid tumors: a systematic review
(SAGE Publications, 2022) -
Cabozantinib for the treatment of solid tumors: a systematic review
(SAGE Publications, 2022-07-13) -
Futibatinib, an Irreversible FGFR1–4 Inhibitor, in Patients with Advanced Solid Tumors Harboring FGF/FGFR Aberrations: A Phase I Dose-Expansion Study
(American Association for Cancer Research, 2022-02-01)